The inflammatory bowel disease (IBD) clinical trials component of the F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute is directed by Gil Melmed, MD. Dr. Melmed facilitates the interface of two very active programs: clinical care and clinical investigation.
A total of 3500 patients with IBD are followed. Each year, more than 2000 patients are seen in the clinical care center, of which 750 are new patients. Another 200 to 300 patients are seen for participation in extra- and intra-murally funded research protocols.
Currently active and enrolling clinical trials:
(Use the following search terms when searching for IBD clinical trials)
- Inflammatory bowel disease
- Crohn’s disease
- Ulcerative colitis
- Regional ileitis
- Fistula, Strictures (Stricturing)